Directory profiles that have not opted in. Name, email, and a private contact are not listed. 52 states. Last updated 2026-10-16. Counts are on the catalog.
Page 777. The contact email is not on this page.
- VentSafe, Inc.
Form D history: Biotechnology
startup · CA · amount not stated · 2023-12-01
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-12-01.
- AUTOMATED IMAGING DIAGNOSTICS, LLC
NIH R42: Clinical performance testing of neuropacs in Parkinsonism diagnosis
startup · FL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BIOINCEPT, LLC
NIH R44: Synthetic PreImplantation Factor (sPIF) plus hypothermia to treat neonatal brain injury
startup · OH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- INTELON OPTICS, INC.
NIH R44: Next-generation Brillouin ocular scanner
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- EXESALIBERO, INC.
NIH R43: Development of the novel small-molecule anti-osteoclastic drug ELP-004 to alleviate the symptoms of osteogenesis imperfecta (OI)
startup · WV · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- INPRINT BIO LLC
NIH R43: MuscleInk: A multifunctional colloidal scaffold for the treatment of muscle loss
startup · CT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- DFUSION, INC.
NIH R44: Scaling Effective Behavioral Interventions with MPC Avatar-Based Virtual Training
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BINARY GENOMICS, INC.
NIH R44: Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA
startup · AZ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- INNOVATION RESEARCH AND TRAINING, INC.
NIH R44: Parent resource to improve communication for adolescent substance use prevention
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- EMBIOSYS INC.
NIH R44: CuRrEnT: Capecitabine in RCB2/3 with a wearable induced Electric field device in Triple Negative Breast Cancer
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PEDIATRIC PSYCHOLOGY PARTNERS, PC D/B/A STREAMIND HEALTH
NIH R43: A Digital Therapy Platform to Improve Access to Cognitive Behavioral Treatment for Youth with Chronic Headaches
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- DATIRIUM, LLC
NIH R41: Bioinformatics pipeline for personalized diagnostics of transplant rejection
startup · OH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- LITTLE ROOM INNOVATIONS, LLC
NIH R43: A Unique Body-Powered Terminal Device with Enhanced Grasping Capabilities for Individuals with Upper Limb Loss
startup · MI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Aakha Biologics, Inc.
Form D history: Biotechnology
startup · TX · amount not stated · 2024-07-17
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2024-07-17.
- AMAHEALTH LLC
NIH R41: Accurate and actionable prediction of impending labor using deep learning on maternal physiological data
startup · AZ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PEPTIFORGE, INC
NIH R43: A platform for the rapid development of protein binders
startup · IL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BIOXYTECH RETINA, INC.
NIH R43: Advancing Public Eye Health through AI-Driven Prediction of Diabetic Retinopathy
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BIOTHERAPEUTICS, INC.
NIH R43: Development of Novel Immunoregulatory Therapeutics for Asthma
startup · VA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MEDARA, INC
NIH R43: A Longitudinal Multimodal Risk Prediction Platform for Personalized Breast Cancer Screening
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ADVAC THERAPEUTIC, LLC
NIH R41: Development of recombinant VSV vaccines for emerging bunyaviruses
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ALPACURE LLC
NIH R43: A single-domain antibody-based lateral flow assay for Tuberculosis
startup · OR · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ANGIOTENSIN THERAPEUTICS, INC.
NIH R41: AGT001 for Delayed Graft Function in Kidney Transplantation
startup · IL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NEURAEGIS, INC.
NIH R41: Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsy
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CELL PRESERVATION SERVICES, INC.
NIH R43: A Novel Multicomponent DMSO Free Cryococktail and Recovery Reagent for the Improved Cryopreservation of NK Cells
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Spectral Labs
Spectral Labs is a spatial intelligence company building reasoning models for engineering physical systems. They have developed SGS-1, a generative model for structured CAD that can generate fully manufacturable and parametric 3D geometry.
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MMJ LABS, LLC
NIH R44: Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
startup · GA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MAXWELL BIOMEDICAL INC
NIH R44: Spatial Resynchronization Therapy for AFib
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ESPIRA, INC.
NIH R44: Fluorescence-solid phase Extraction (F-SPE) Microfluidic Platform for Rapid, Onsite Detection and Identification of PFAS with Machine Learning
startup · UT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- 5 POINT APP
NIH R44: Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- INNOVATIVE DESIGN LABS, INC.
NIH R44: PhysioSim: Innovative Physiology Simulation Education Kits for Pre-College Students and Teachers
startup · MN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- IMMUNOSHIELD THERAPEUTICS INC.
NIH R44: Hydrogel injection molded islet macroencapsulation devices to treat diabetes in a non-human primate model
startup · AZ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ANEUVAS TECHNOLOGIES, INC.
NIH R41: Development of a novel biocompatible polymer coating for aneurysm treatment devices
startup · AZ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ASTROCYTE PHARMACEUTICALS, INC.
NIH R41: Preclinical efficacy of AST-004 as a treatment for substance use disorder
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- OLFAX, LLC
Form D history: Pharmaceuticals
startup · NC · amount not stated · 2024-06-11
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2024-06-11.
- ACPHARIS, INC.
NIH R43: Software for increased accuracy prediction of antibody-antigen complexes
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AI SOLUTIONS 87 LLC
NIH R43: AIS Comprehensive Radon Intelligence Platform: A Connected Ecosystem for Radon Awareness, Decision Support, and Mitigation.
startup · WI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- EV2 TECHNOLOGIES, INC.
NIH R44: Development and Chronic Preclinical Assessment of a Flexible Endovascular Scaffold for Treating Stenosis in the Femoropopliteal Arterial Segments
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VINCERE BIOSCIENCES, INC.
NIH R43: In vivo Evaluation of USP30 Inhibitors in Models Relevant to Parkinson's Disease
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CHEMIA BIOSCIENCES, INC.
NIH R44: A novel platform for nonribosomal peptide discovery
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NARWHAL BIO, INC.
NIH R43: A Universal Tool for Unravelling the Requirements for Clinically Relevant Cell-Cell Interactions via In Situ Phenotyping and Tagging of Live Cells
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.